Search Results 861-870 of 16404 for monoclonal antibody

1. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...

2. Tumors And Masses Clinical Trials - Mayo Clinic Research

   ... Monoclonal Antibodies Scottsdale/Phoenix, AZ. The main purpose of this study is to determine the best dose of MEDI6469 that is safe and tolerable when given ...

3. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

   Prior antibody treatment for cancer must have been ... Sacituzumab govitecan-hziy is an antibody-drug conjugate that combines a humanized monoclonal ...

4. Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma - Mayo Clinic

   ... monoclonal antibody specific for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled ...

5. A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy - Mayo Clinic

   The purpose of this study is to determine how many rounds of plasma exchange are required for maximal decrease in measles antibodies and how long it may last, ...

6. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

   Prior severe infusion reaction to a monoclonal antibody. Severe, active co-morbidity, defined as follows: Significant history of uncontrolled cardiac ...

7. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are working to improve the diagnosis and treatment of MOGAD . Specific efforts include increasing the recognition on how to diagnose ...

8. A Study of the Natural History of Monoclonal Gammopathy of Undetermined Significance (MGUS) Over Time - Mayo Clinic

   The primary purpose of this study is to evaluate the risk of progression from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myleoma (MM) ...

9. Cellular Therapy Clinical Trials - Mayo Clinic Research

   ... antibody (ANCA) associated vasculitis using primary samples and/or patient ... Monoclonal antibodies, such as pembrolizumab, may block tumor growth in ...

10. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    * Any previous treatment with anti-CD19 antibody, complement inhibitors, neonatal Fc receptor antagonists, anti-B-lymphocyte stimulator monoclonal antibody * ...